-
"Pharmaceutical Speed Reader" Considine won the IPO approval of The Board of Science
Time of Update: 2020-08-03
collection, drug price recruitment credit evaluation system. (Heilongjiang Medical Insurance Bureau) Part 2 production observed that Consino was approved by the IPO of the first A-H vaccine shares on the 15th, the CSRC issued a number of enterprises
-
"Pharmaceutical Speed Reader" people Fu PharmaceuticalSa-Ylun China was approved deqi medicine to complete the C round of financing.
Time of Update: 2020-08-03
risk area cleared zero. (Beijing epidemic prevention and control press conference) the state sent a strong grass-roots: prohibit higher-level hospitals "siphon-type" to dig up talent recently, the Ministry of Human Resources and Social Security
-
"Pharmaceutical Speed Reader" thousands of yam machine to end the listing of Junshi biological landing branch of the first day of the surge.
Time of Update: 2020-08-03
of counterfeit drugs. reply notes that there are six cases in which the quality inspection conclusions of the drug inspection institution need not be specified in the decision on the punishment of counterfeit and inferior drugs. (State Drug
-
The "Pharmaceutical Speed Reader" collection is intended to incorporate the sale of SYK inhibitor assets by Gilead in Biologics.
Time of Update: 2020-08-03
after completing Phase 3 clinical trials. (Pharmaceutical Mission) Part 3 Drug Information Therapy Alzheimer's Anti-Tau Vaccine Launch Phase 1b/2a Trial, Switzerland-based clinical phase AC Immune SA announced that it will launch its Alzheimer's
-
"Pharmaceutical Speed Reader" Kaixin as far as 38 million U.S. dollars to raise three generic drugs were approved.
Time of Update: 2020-08-02
3 clinical reached the main end point; innovative cardiomyopathy targeted therapy was recognized by the FDA for breakthrough therapy; and the National Drug Administration announced: a batch of drugs discontinued, recalled... Daily fresh medicine
-
"Pharmaceutical Speed Reader" Sansheng Guoke Co., Inc. IPO ipo of Gilead's $1.25 billion deal.
Time of Update: 2020-08-02
50.1 percent of the latter, with future exercise fees and potential mileage of $1.25 billion. Gilead funded Tizona to develop differentiated first in class oncology immunotherapy. (Pharmaceutical Rubik's Cube) Part 3 Drug Information
-
"Pharmaceutical Speed Reader" Yan Jian and another senior executive leave "limited resistance order" to upgrade.
Time of Update: 2020-08-02
July 23, 2020 / Medical Information List: Another executive leaves, the State Council: the key tasks for deepening the reform of the medical and health system in the second half of the year; the re-escalation of the "resistance restraining order
-
"Pharmaceutical Speed Reader" mRNA vaccine start phase 3 clinical multi-drug recommended by the European Union approval.
Time of Update: 2020-08-02
in the Priority Review; AstraZeneca Calquence has been approved by the European Union for the treatment of adult Patients with CLL... Daily fresh medicine to hear medical news, fast-reading society with you to pay attention! Part 1 Policy Brief July 27
-
The results of the clinical trial of the new crown vaccine of the "Pharmaceutical Speed Reader
Time of Update: 2020-08-02
July 21, 2020 / Medical Information List: The results of clinical trials of two new crown vaccines are available; the application for a chinese listing in DingRiptini was accepted for treatment of gastrointestinal interstitial tumors; Beida
-
"Pharmaceutical Speed Reader" Amjin Enbrel patent won the case of 9 drugs discontinued, recalled.
Time of Update: 2020-07-24
the National Drug Administration: 9 drugs discontinued, recalled; Amgen Enbrel patent winning U.S. market exclusive period extended to 2029; Sanofi/Regenerative Kevzara treatment phase III clinical failure; Sarepta reached a $400 million
-
"Pharmaceutical Speed Reader" FDA released the new crown vaccine listing standard Junshi issue price set at 55.5 yuan.
Time of Update: 2020-07-24
the price of the new crown virus detection reagent linked; Junshi biological issue price is set at 55.5 yuan; Inovio new crown vaccine phase 1 clinical immune response rate of 94%; The drug, car-t-T, is on the market, and the FDA has issued
-
"Pharmaceutical Speed Reader" 2020 edition of the Chinese Pharmacopeia promulgated the second domestic two-price HPV vaccine reported.
Time of Update: 2020-07-24
the 2020 edition of the Pharmacopoeia of the People's Republic of China, the second batch of two-month Abitron procurement volume has been completed nearly seven times, Mylan shareholders through a merger with Puqiang new company Viatris
-
"Pharmaceutical Speed Reader" Kangji Medical Hkex listed Kangsino recombined the new crown vaccine approved.
Time of Update: 2020-07-24
Fujian medical supplies with a volume of procurement enterprises announced; Shaanxi Province Drug Administration to implement a blacklist system; Taibang biological claims to Xinjiang Deyuan more than 460 million yuan; Soyuan biological
-
"Pharmaceutical Speed Reader" step-by-step pharmaceutical sales of Hubei Kyushu Tong equity a number of pharmacies to write off the de-listing.
Time of Update: 2020-07-23
(Biological Valley) Cancer Prevention Pharmaceuticals recently announced that it has submitted a new drug application to the U.S. FDA to seek accelerated approval of CPP-1X/sul for the treatment of adult familial adenoma polyps.
-
The price of Chinese herbal medicines fell sharply by the "Pharmaceutical Speed Reader Society
Time of Update: 2020-07-23
Keytruda-Lenvima combination of first-line treatment of liver cancer rejected; treatment of bald ness Concert innovative JAK oral inhibitors approved by the FDA breakthrough therapy; Zezen Pharmaceuticals Donafini and anti-PD-1 monoantitherapy
-
The "Pharmaceutical Speed Reader" market was advised to withdraw the bankruptcy and reorganization of the controlling shareholders of Yuheng Pharmaceuticals.
Time of Update: 2020-07-23
single city drug collection was "advised to withdraw"; Xu Xinhua, president of Zhongzhu Medical, resigned; Yu Heng Pharmaceuticals' controlling shareholder filed for bankruptcy reorganization; and NMPA released three heavyweight documents
-
"Pharmaceutical Speed Reader" Baiji financing 2.08 billion U.S. dollars Enhua children's new products proposed priority review.
Time of Update: 2020-07-21
July 14, 2020 / Medical Information List: Baiji Shenzhou raised a record $2.08 billion; the development of a potential cure for HIV, Mersadon, reached a $300 million cooperation; Junshi Bio and REVITOPE signed a research and development cooperation
-
"Medical Speed Reader" rabies vaccine shortage Micro-medical plans to go to Hong Kong IPO in the third quarter of this year
Time of Update: 2020-07-09
Health Insurance Administration issues interim measures for the management of basic medical supplies for medical care; shortage of rabies vaccines in many places; IPO of micro-medicine in The Third Quarter of this year; Sanofi and Corning
-
"Pharmaceutical Speed Reader" 4 plus 7 expansion varieties again appear shortage Takeda Walker layout China market
Time of Update: 2020-07-09
186 drugs transferred out of Guangxi medical insurance; new three-plate transfer to the main board 6 pharmaceutical companies sprint first; Lilly insulin glargine treatment of China's adult type 2 diabetes phase III clinical reach the main end
-
"Pharmaceutical Speed Reader" local health insurance 3 years of retirement varieties announced spread AZ want to buy Gilead
Time of Update: 2020-07-09
3-year digestion principle of health insurance supplementary drugs in Chongqing; Net-a-Porter AstraZeneca wants to acquire Gilead; China's first new crown neutralizing antibody launch clinical trial; Guangshengtang anti-hepatitis b virus drug
